Editorial Commentary: Should “heterogeneous response” be considered as new category for assessing treatment response in patients with breast cancer?

European Journal of Nuclear Medicine and Molecular Imaging, vol. 52, pp. 801–805

Authors 9

1. Sofia Carrilho Vaz Aachen Department of Radiology, Leiden University Medical Center

   Champalimaud Foundation · Leiden University Medical Center

   Affiliation as printed

   Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands

   Nuclear Medicine- Radiopharmacology, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal

2. David Groheux

   Inserm · Hôpital Saint-Louis · Université Paris Diderot · HIPI - Immunologie humaine, physiopathologie et immunithérapie

   Affiliation as printed

   Centre d'Imagerie Radio-Isotopique (CIRI), La Rochelle, France

   Nuclear Medicine Department, Saint- Louis Hospital, Paris, France

   University Paris-Diderot, INSERM U976, Paris, France

3. Thiemo J. A. van Nijnatten

   Maastricht University Medical Centre · Maastricht University

   Affiliation as printed

   Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands

   NUTRIM, Maastricht University Medical Center+, Maastricht, the Netherlands

4. Lidija Antunovic

   IRCCS Ospedale San Raffaele

   Affiliation as printed

   Department of Nuclear Medicine, Ospedale San Raffaele, Milan, Italy

5. Fátima Cardoso

   Champalimaud Foundation · Centro Champalimaud

   Affiliation as printed

   Advanced Breast Cancer Global Alliance, Lisbon, Portugal

   Breast Unit, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal

6. Felix Manuel Mottaghy Aachen Department of Nuclear Medicine

   Maastricht University Medical Centre · Maastricht University · Universitätsklinikum Aachen · RWTH Aachen University

   Affiliation as printed

   Department of Nuclear Medicine, University Hospital, RWTH Aachen University, Aachen, Germany

   Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands

   GROW- Research institute for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, the Netherlands

7. Maria João Cardoso

   Champalimaud Foundation · Centro Champalimaud · Universidade Nova de Lisboa

   Affiliation as printed

   Breast Unit, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal

   NOVA medical school, Lisbon, Portugal

8. Lioe‐Fee de Geus‐Oei Aachen Department of Radiology, Leiden University Medical Center

   Leiden University Medical Center · University of Twente · Delft University of Technology

   Affiliation as printed

   Biomedical Photonic Imaging Group, University of Twente, Enschede, The Netherlands

   Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands

   Department of radiation Science & Technology, Technical University of Delft, Delft, The Netherlands

9. Gary A. Ulaner corresponding

   University of Southern California · Hoag Memorial Hospital Presbyterian

   Affiliation as printed

   Molecular Imaging and Therapy, Hoag Family Cancer Institute, Newport Beach, CA, USA. Gary.Ulaner@hoag.org

   University of Southern California, Los Angeles, CA, USA. Gary.Ulaner@hoag.org

   Molecular Imaging and Therapy, Hoag Family Cancer Institute, Newport Beach, CA, USA

   University of Southern California, Los Angeles, CA, USA